Mounjaro 15mg Injection (Tirzepatide) is an advanced medication designed to help manage type 2 diabetes in adults. Manufactured by Eli Lilly, this injection acts as a dual GIP and GLP-1 receptor agonist — meaning it targets two natural incretin hormones to enhance insulin secretion and control glucose levels. Each pre-filled pen delivers 15mg of Tirzepatide in 0.5mL solution, providing a convenient once-weekly dosage. Mounjaro not only helps reduce blood sugar but also supports weight management in diabetic patients when used alongside proper diet and exercise.It should be administered under the guidance of a healthcare professional, typically injected subcutaneously in the abdomen, thigh, or upper arm. Key Benefits: Helps manage type 2 diabetes Supports weight loss in some patients Once-a-week injection for convenience Developed by Eli Lilly, ensuring high quality and effectiveness Storage: Store in a refrigerator (2°C–8°C). Do not freeze.Pack Contains: 15mg/0.5mL x 2 pre-filled pens
